Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Egypt

Egypt

Egypt is projected to see a significant increase in revenue in the Treatment of Cardiovascular Diseases market.
By 2024, the revenue is estimated to reach US$0.95bn.
This is expected to continue growing at an annual growth rate (CAGR 2024-2029) of 12.34%, resulting in a market volume of US$1.70bn by 2029.
When compared globally, it is worth noting that United States is expected to generate the highest revenue in this market.
In 2024, United States is projected to generate US$136.00bn.
Egypt is experiencing a rise in the adoption of advanced cardiovascular treatments, leading to improved outcomes for patients.

Key regions: Germany, France, Japan, Europe, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.